PETER DANIEL CANOLL, M.D., PHD
Medical Practice at 168 St, New York, NY
License number
New York 218045-1
Category
Medical Practice
Type
Neuropathology
License number
New York 218045-1
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
622 W 168Th St PH 1564W, New York, NY 10032
Phone
(212) 305-7399
Personal information
See more information about PETER DANIEL CANOLL at radaris.comName
Address
Phone
601 W 113Th St APT 12E, New York, NY 10025
445 68Th St, New York, NY 10021
75 End Ave, New York, NY 10023
Professional information
See more information about PETER DANIEL CANOLL at trustoria.com
Neuropathologist
Neuropathologist
Position:
Associate Professor of Pathology and Cell Biology at Columbia University Medical Center
Location:
Greater New York City Area
Industry:
Higher Education
Work:
Columbia University Medical Center
- New York since Jul 2000
-
Associate Professor of Pathology and Cell Biology
Education:
New York University School of Medicine 1989 - 1998
MD. PhD., Neuroscience Brown University 1985 - 1988
Sc.B., Neuroscience
MD. PhD., Neuroscience Brown University 1985 - 1988
Sc.B., Neuroscience
Peter Daniel Canoll, New York NY
Peter Daniel Canoll, New York NY
Specialties:
Pathologist
Address:
622 W 168Th St, New York, NY 10032
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Neuropathology (Pathology)
Dr. Peter D Canoll, New York NY - MD (Doctor of Medicine)
Dr. Peter D Canoll, New York NY - MD (Doctor of Medicine)
Specialties:
Neuropathology
Address:
1130 Saint Nicholas Ave SUITE 1001A, New York 10032
(212) 851-4632 (Phone), (212) 305-4548 (Fax)
W 1562
630 W 168Th St SUITE 15, New York 10032
(212) 305-9235 (Phone), (212) 305-5958 (Fax)
(212) 851-4632 (Phone), (212) 305-4548 (Fax)
W 1562
630 W 168Th St SUITE 15, New York 10032
(212) 305-9235 (Phone), (212) 305-5958 (Fax)
Certifications:
Anatomic Pathology, 2003, Neuropathology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York University
Graduated: 1993
New York Presbyterian Hospital
New York University
Graduated: 1993
New York Presbyterian Hospital
Inhibitors Of Dynein Or Lissencephaly 1, And Methods Of Using Same For Treatment Of Neuronal Disorders
Inhibitors Of Dynein Or Lissencephaly 1, And Methods Of Using Same For Treatment Of Neuronal Disorders
US Patent:
2007021, Sep 13, 2007
Filed:
Sep 6, 2006
Appl. No.:
11/516204
Inventors:
Richard Vallee - Dobbs Ferry NY, US
Peter Canoll - New York NY, US
James Goldman - White Plains NY, US
Peter Canoll - New York NY, US
James Goldman - White Plains NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 48/00, C07H 21/02
US Classification:
514044000, 536023100
Abstract:
The invention provides antagonists and agonists of dynein mediated activity, for example specific inhibitory RNAs and dominant negative cDNAs which function as antagonists of LIS1 and dynein, and compositions comprising such antagonist and agonists. Provided are also methods for treating unwanted cell proliferation of neural progenitor cells such as cancers of the CNS, including gliomas, by administering the antagonists of the invention.
In Vivo Amplification Of Neural Progenitor Cells
In Vivo Amplification Of Neural Progenitor Cells
US Patent:
2008015, Jun 26, 2008
Filed:
Jun 21, 2007
Appl. No.:
11/821086
Inventors:
Peter Canoll - New York NY, US
James Goldman - White Plains NY, US
Marcela Assanah - East Elmhurst NY, US
Sanja Ivkovic - New York NY, US
James Goldman - White Plains NY, US
Marcela Assanah - East Elmhurst NY, US
Sanja Ivkovic - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 35/30, C12N 5/02, C12N 15/87, G01N 33/53, A61P 25/00, A01K 67/027, A61K 31/7088
US Classification:
435464, 435375, 514 44, 424 9321, 800 10, 800 3
Abstract:
The invention is directed to methods for in vivo amplification of neural progenitor cells using the proliferative environment of glial neoplasms in adult brain. The progenitor cells have the capacity to proliferate and differentiate into mature brain cells which can be used for cell replacement therapies. The invention also provides cell replacement therapy methods for treating central nervous system diseases or injuries, including multiple sclerosis, stroke, Alzheimer's disease and Parkinson's disease.